18.78 USD
-0.37 (-1.93%)
18.78 USD
0 (0%)
Overall ALHC gets a fundamental rating of 3 out of 10. We evaluated ALHC against 102 industry peers in the Health Care Providers & Services industry. ALHC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALHC is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
ALHC had negative earnings in the past year.
In the past year ALHC had a positive cash flow from operations.
In the past 5 years ALHC always reported negative net income.
In multiple years ALHC reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of ALHC (-1.89%) is comparable to the rest of the industry.
The Return On Equity of ALHC (-12.86%) is worse than 60.78% of its industry peers.
ALHC has a Return On Invested Capital (0.40%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.89% | ||
| ROE | -12.86% | ||
| ROIC | 0.4% |
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 0.07%, ALHC is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
ALHC has a worse Gross Margin (12.42%) than 69.61% of its industry peers.
In the last couple of years the Gross Margin of ALHC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.07% | ||
| PM (TTM) | N/A | ||
| GM | 12.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
2. Health
2.1 Basic Checks
ALHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALHC has more shares outstanding
The number of shares outstanding for ALHC has been increased compared to 5 years ago.
ALHC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.89 indicates that ALHC is not in any danger for bankruptcy at the moment.
ALHC has a better Altman-Z score (4.89) than 83.33% of its industry peers.
The Debt to FCF ratio of ALHC is 2.14, which is a good value as it means it would take ALHC, 2.14 years of fcf income to pay off all of its debts.
ALHC has a Debt to FCF ratio of 2.14. This is in the better half of the industry: ALHC outperforms 79.41% of its industry peers.
ALHC has a Debt/Equity ratio of 1.99. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.99, ALHC is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for ALHC, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.99 | ||
| Debt/FCF | 2.14 | ||
| Altman-Z | 4.89 |
ROIC/WACC0.04
WACC9%
2.3 Liquidity
ALHC has a Current Ratio of 1.61. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALHC (1.61) is better than 60.78% of its industry peers.
ALHC has a Quick Ratio of 1.61. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.61, ALHC is doing good in the industry, outperforming 63.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.71%, which is quite impressive.
ALHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.39%.
Measured over the past years, ALHC shows a very strong growth in Revenue. The Revenue has been growing by 28.99% on average per year.
EPS 1Y (TTM)85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.29%
Revenue 1Y (TTM)47.39%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%43.51%
3.2 Future
Based on estimates for the next years, ALHC will show a very strong growth in Earnings Per Share. The EPS will grow by 33.00% on average per year.
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 28.41% on average per year.
EPS Next Y83.79%
EPS Next 2Y46.5%
EPS Next 3Y37.01%
EPS Next 5Y33%
Revenue Next Year46.96%
Revenue Next 2Y38.02%
Revenue Next 3Y33.83%
Revenue Next 5Y28.41%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 191.79, which means the current valuation is very expensive for ALHC.
Based on the Price/Forward Earnings ratio, ALHC is valued a bit more expensive than the industry average as 60.78% of the companies are valued more cheaply.
ALHC is valuated expensively when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 191.79 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALHC is valued a bit more expensive than the industry average as 63.73% of the companies are valued more cheaply.
ALHC's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.96 | ||
| EV/EBITDA | 109.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ALHC's earnings are expected to grow with 37.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.5%
EPS Next 3Y37.01%
5. Dividend
5.1 Amount
No dividends for ALHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
18.78
-0.37 (-1.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.7%
Inst Owner Change-1.02%
Ins Owners4.13%
Ins Owner Change-3.2%
Market Cap3.76B
Revenue(TTM)3.64B
Net Income(TTM)-20.81M
Analysts85.26
Price Target21.63 (15.18%)
Short Float %9.09%
Short Ratio6.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)159.73%
Min EPS beat(2)124.15%
Max EPS beat(2)195.32%
EPS beat(4)4
Avg EPS beat(4)99.79%
Min EPS beat(4)18.53%
Max EPS beat(4)195.32%
EPS beat(8)6
Avg EPS beat(8)49.21%
EPS beat(12)9
Avg EPS beat(12)37.52%
EPS beat(16)13
Avg EPS beat(16)34.96%
Revenue beat(2)1
Avg Revenue beat(2)1.46%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)3.66%
Revenue beat(4)3
Avg Revenue beat(4)1.7%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)3.66%
Revenue beat(8)7
Avg Revenue beat(8)2.53%
Revenue beat(12)10
Avg Revenue beat(12)2.34%
Revenue beat(16)14
Avg Revenue beat(16)3.17%
PT rev (1m)9.01%
PT rev (3m)9.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.13%
EPS NY rev (1m)14.46%
EPS NY rev (3m)41.91%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)2.69%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 191.79 | ||
| P/S | 1.03 | ||
| P/FCF | 24.96 | ||
| P/OCF | 20.69 | ||
| P/B | 23.21 | ||
| P/tB | 30 | ||
| EV/EBITDA | 109.07 |
EPS(TTM)-0.11
EYN/A
EPS(NY)0.1
Fwd EY0.52%
FCF(TTM)0.75
FCFY4.01%
OCF(TTM)0.91
OCFY4.83%
SpS18.18
BVpS0.81
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.89% | ||
| ROE | -12.86% | ||
| ROCE | 0.51% | ||
| ROIC | 0.4% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 0.07% | ||
| PM (TTM) | N/A | ||
| GM | 12.42% | ||
| FCFM | 4.14% |
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
F-Score6
Asset Turnover3.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.99 | ||
| Debt/FCF | 2.14 | ||
| Debt/EBITDA | 10.1 | ||
| Cap/Depr | 105.36% | ||
| Cap/Sales | 0.85% | ||
| Interest Coverage | 0.19 | ||
| Cash Conversion | 568.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 4.89 |
F-Score6
WACC9%
ROIC/WACC0.04
Cap/Depr(3y)151.69%
Cap/Depr(5y)136.01%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.29%
EPS Next Y83.79%
EPS Next 2Y46.5%
EPS Next 3Y37.01%
EPS Next 5Y33%
Revenue 1Y (TTM)47.39%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%43.51%
Revenue Next Year46.96%
Revenue Next 2Y38.02%
Revenue Next 3Y33.83%
Revenue Next 5Y28.41%
EBIT growth 1Y102.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.72%
EBIT Next 3Y59.42%
EBIT Next 5Y46.99%
FCF growth 1Y385.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y968.86%
OCF growth 3YN/A
OCF growth 5Y30.43%
ALIGNMENT HEALTHCARE INC / ALHC FAQ
What is the fundamental rating for ALHC stock?
ChartMill assigns a fundamental rating of 3 / 10 to ALHC.
What is the valuation status of ALIGNMENT HEALTHCARE INC (ALHC) stock?
ChartMill assigns a valuation rating of 1 / 10 to ALIGNMENT HEALTHCARE INC (ALHC). This can be considered as Overvalued.
How profitable is ALIGNMENT HEALTHCARE INC (ALHC) stock?
ALIGNMENT HEALTHCARE INC (ALHC) has a profitability rating of 1 / 10.
How financially healthy is ALIGNMENT HEALTHCARE INC?
The financial health rating of ALIGNMENT HEALTHCARE INC (ALHC) is 5 / 10.
What is the expected EPS growth for ALIGNMENT HEALTHCARE INC (ALHC) stock?
The Earnings per Share (EPS) of ALIGNMENT HEALTHCARE INC (ALHC) is expected to grow by 83.79% in the next year.